Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Not a Member?

Create Account and Join

Walter E. Washington Convention Center

Jun 14, 2015 2:30 PM - Jun 18, 2015 6:45 PM

801 Mount Vernon Place, NW, , Washington, DC 20001-3614 , USA

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="http://www.diaglobal.org/Flagship-Meetings/DIA-Annual-Meeting/Meeting-Program/ePac-Presentations-Access.aspx">Review Presentations </A>

Back to Agendas

A Systematic Approach to Study Start-Up

Session Chair(s)

Marina Alexandra Malikova, PhD, MBA, MS, RAC

Executive Director, Translational Research, Assistant Professor of Surgery

Boston University School of Medicine, United States

Systematic assessment of risk factors and key performance indicators at a start-up phase can allow for more efficient execution of a clinical trial and ensure better accrual rates. This session will discuss best practices to expedite start-up phase.

Learning Objective : Develop a sound business strategy for a more efficient study start-up; Determine key performance indicators and risk factors contributing to the delays at the start-up phase; Implement mitigation strategy in order to avoid delays and allow for successful launch of a clinical trial.

Speaker(s)

IRB Performance Metrics: Data From 105 Institutions Defining the Current State and Implications for Clinical Trials

Stuart Horowitz, PhD, MBA

WCG IRB, United States

President, Institutions & Institutional Services

A Systematic Approach to Study Start-Up: Applying Quality Risk Management to Clinical Studies

Marc Jason DeLuca, MS

InVentiv Health Clinical, United States

Associate Director, QRM Group

Have an account?

Ways to register

Registration override should work.